Impact of screening on breast cancer mortality: The UK program 20 years on

Cancer Epidemiology Biomarkers and Prevention

Volumn 25, Issue 3, 2016, Pages 455-462

  Massat, Nathalie J ^a   Dibden, Amanda ^a   Parmar, Dharmishta ^a   Cuzick, Jack ^a   Sasieni, Peter D ^a   Duffy, Stephen W ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CASE CONTROL STUDY; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POPULATION; PRIMARY HEALTH CARE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; UNITED KINGDOM; BREAST NEOPLASMS; EARLY CANCER DIAGNOSIS; MASS SCREENING; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; SURVIVAL RATE; UNITED KINGDOM;

EID: 84961243857     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0803     Document Type: Article

References (39)

1. Shapiro S, Venet W, Strax P, Venet L, Roeser R. Selection, follow-up, and analysis in the Health Insurance Plan Study: a randomized trial with breast cancer screening. Natl Cancer Inst Monogr 1985;67:65-74.
2. Tabar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the breast cancer screening working group of the swedish national board of health and welfare. Lancet 1985;1:829-32.
3. Advisory Committee on Breast Cancer Screening. Screening for breast cancer in England: past and future. NHS Cancer Screening Programmes; 2006. Available from: http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp61.html.
4. PublicHealthEngland (PHE).NHS Breast Screening Programme(NHSBSP). 2015; Available from: http://www.cancerscreening.nhs.uk/breastscreen/.
5. Cancer Research UK (CRUK). Breast cancer statistics 2011; 2014. Available from: http://www.cancerresearchuk.org/cancer-info/cancerstats/types/breast.
6. Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer 2013;108:2205-40.
7. Broeders M, Moss S,NystromL, Njor S, JonssonH, Paap E, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of observational studies. J Med Screen 2012;19:14-25.
8. El Saghir NS, Keating NL, Carlson RW, Khoury KE, Fallowfield L. Tumor boards: optimizing the structure and improving efficiency of multidisciplinary management of patients with cancer worldwide.AmSoc Clin Oncol Educ Book 2014:e461-6. doi: 10.14694/EdBook-AM.2014.34.e461.
9. Guarneri V, Conte PF. The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging 2004;31(Suppl 1): S149-61.
10. Tryfonidis K, Senkus E, Cardoso MJ, Cardoso F. Management of locally advanced breast cancer-perspectives and future directions. Nat Rev Clin Oncol 2015;12:147-62.
11. Patnick J. NHS breast screening: the progression from one to two views. J Med Screen 2004;11:55-6.
12. National Institute for Health & Care Excellence (NICE). Improving outcomes in breast cancer (CSGBC). NICE guidelines; 1996. Available from: https://www.nice.org.uk/guidance/csgbc.
13. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data. BMJ 2009;339:b2968.
14. Sasieni P, Castanon A. NHSCSP audit of invasive cervical cancer: national report 2007-2011-Section 4.6.4. NHSCSP; 2012. Available from: http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp-audit-invasivecervical-cancer.html.
15. Demissie K, Mills OF, Rhoads GG. Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screeningmammography. J Clin Epidemiol 1998;51:81-91.
16. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92.
17. Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence andmetastasis: a systematic comparison of evidence fromobservational studies versus randomised trials. Lancet Oncol 2012;13:518-27.
18. Tabar L, Fagerberg G, Duffy SW, Day NE, Gad A, Grontoft O. Update of the Swedish two-county program of mammographic screening for breast cancer. Radiol Clin N Am 1992;30:187-210.
19. Duffy SW, Cuzick J, Tabar L, Vitak B, Hsiu-Hsi Chen T, Yen M-F, et al. Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J Royal Stat Soc: Series C 2002;51:235-43.
20. Nickson C,Mason KE, English DR, Kavanagh AM. Mammographic screening and breast cancer mortality: a case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 2012;21:1479-88.
21. PaapE,VerbeekALM,BotterweckAAM,vanDoorne-NagtegaalHJ, Imhof-Tas M, de Koning HJ, et al. Breast cancer screening halves the risk of breast cancer death: a case-referent study. The Breast 2014;23:439-44.
22. Health & Social Care Information Centre (HSCIC). Breast Screening Programme, England Statistics for 2008-09; 2009. Available from: http://www. cancerscreening.nhs.uk/breastscreen/breast-statistics-bulletin-2008-09.pdf.
23. Massat NJ, Sasieni PD, Parmar D, Duffy SW. An ongoing case-control study to evaluate the NHS breast screening programme. BMC Cancer 2013;13:596.
24. Machin D, Campbell M, Fayers P, Pinol A. Sample size tables for clinical studies. Oxford, United Kingdom: Blackwell; 1997.
25. Massat NJ, Sasieni PD, Duffy SW. A new approach to estimate the underlying risk of outcome in studies of cancer screening. Submitted to Statistical Methods in Medical Research.
26. Connor RJ, Boer R, Prorok PC, Weed DL. Investigation of design and bias issues in case-control studies of cancer screening using microsimulation. Am J Epidemiol 2000;151:991-8.
27. JonssonH,Nystrom L, Tornberg S, Lundgren B, Lenner P. Service screening with mammography. Long-term effects on breast cancer mortality in the county of Gavleborg, Sweden. Breast 2003;12:183-93.
28. Fielder HM, Warwick J, Brook D, Gower-Thomas K, Cuzick J, Monypenny I, et al. A case-control study to estimate the impact on breast cancer death of the breast screening programme in Wales. J Med Screen 2004;11:194-8.
29. Moss SM, Summerley ME, Thomas BT, Ellman R, Chamberlain JO. A casecontrol evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Community Health 1992;46:362-4.
30. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW. A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 2008;98:206-9.
31. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW. A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 2007;48:948-55.
32. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, et al. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008;99:423-7.
33. Roder D, Houssami N, Farshid G, Gill G, Luke C, Downey P, et al. Population screening and intensity of screening are associated with reduced breast cancer mortality: evidence of efficacy of mammography screening in Australia. Breast Cancer Res Treat 2008;108:409-16.
34. van Schoor G, Moss SM, Otten JDM, Donders R, Paap E, den Heeten GJ, et al. Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer 2011;104:910-4.
35. Otto SJ, Fracheboud J, Verbeek ALM, Boer R, Reijerink-Verheij JCIY, Otten JDM, et al. Mammography screening and risk of breast cancer death: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2012;21:66-73.
36. Collette HJ, deWaard F, Rombach JJ, Collette C, Day NE. Further evidence of benefits of a (non-randomised) breast cancer screening programme: the DOM project. J Epidemiol Community Health 1992;46:382-6.
37. Miltenburg GA, Peeters PH, Fracheboud J, Collette HJ. Seventeen-year evaluation of breast cancer screening: the DOM project, The Netherlands. Diagnostisch Onderzoek (investigation) Mammacarcinoom. Br J Cancer 1998;78:962-5.
38. Whelan JM, Griffith CDM, Archer T. Breast cancer multi-disciplinary teams in England: much achieved but still more to be done. Breast 2006;15:119-22.
39. van der Waal D, Broeders MJ, Verbeek AL, Duffy SW, Moss SM. Case-control studies on the effectiveness of breast cancer screening: insights from the UK age trial. Epidemiology 2015;26:590-6.